Come up with a name for your new list and we'll add to it:
Cytovance Biologics raised a round of funding on March 15, 2011. Investors include
Great Point Partners.
Cytovance Biologics is a biopharmaceutical contract manufacturing company specializing in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentat…